A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants
Status:
Terminated
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of
JNJ-56136379 in adult participants with renal impairment compared with healthy participants
with normal renal function.